Navigation Links
Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
Date:10/14/2010

THOUSAND OAKS, Calif., Oct. 14 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced that results from several Prolia™ (denosumab) studies, as well as analyses of the growing global burden of osteoporosis, will be presented at the 2010 American Society for Bone and Mineral Research (ASBMR) annual meeting in Toronto, Ontario from Oct. 15-19, 2010.  

"The continued need to reduce fractures caused by postmenopausal osteoporosis is reinforced by data that will be presented at this year's ASBMR meeting. These data highlight the global economic burden associated with osteoporotic fractures, the challenges with adherence to oral therapies, and the link between adherence and fracture outcomes," said Catherine Stehman-Breen, M.D., vice president of Global Development at Amgen.  "Additionally, safety and efficacy results from the Prolia FREEDOM extension study will be available along with two new analyses of FREEDOM that evaluated the effect of Prolia on bone strength."

ASBMR abstracts are available and can be viewed online at www.asbmr.org.  Identified below are selected abstracts of interest on Amgen research.  Prolia Clinical Data

  • Hip QCT Results From the FREEDOM Trial: Evidence for Positive BMD/BMC Changes in Integral, Trabecular, and Cortical Bone With DenosumabLead Author: Prof. Harry K. Genant, University of California, San FranciscoAbstract No. FR0410 Oral Plenary/Poster Presentation(Friday, Oct. 15, 5:10 p.m.-5:15 p.m. ET)


  • Four years of denosumab exposure in women with PMO: Results from the first year extension of the FREEDOM TrialLead Author: Socrates Papapoulos, Leiden University Medical Center, The NetherlandsAbstract No. 1025 Oral Presentation(Saturday, Oct. 16, 10:00 a.m.-10:15 a.m. ET)


  • Denosumab Improv
    '/>"/>


  • SOURCE Amgen
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related biology technology :

    1. Amgens Roger M. Perlmutter, M.D., Ph.D., Named 2009 AAAS Fellow, Recognized for Discovery, Development of Novel Medicines
    2. Array BioPharma and Amgen Partner in Type 2 Diabetes
    3. Amgen to Present at Lazard Capital Healthcare Conference
    4. Amgen Announces Webcast of 2009 Third Quarter Financial Results
    5. Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference
    6. Amgen to Present at the Morgan Stanley Global Healthcare Unplugged Conference
    7. Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO)
    8. Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August
    9. Amgen Exercises Option for Exclusive License to Cytokinetics Cardiac Contractility Program That Includes CK-1827452
    10. Amgen Announces Voting Results Of Annual Meeting Of Stockholders
    11. Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/24/2014)... -- Research and Markets has announced the ... Instruments Market 2014-2018" report to their offering. ... is the study of the gene and its functions ... functions of proteomes or sets of proteins by using ... the mapping of genes and DNA sequencing to understand ...
    (Date:7/24/2014)... 24, 2014  CorMedix Inc. (NYSE MKT: CRMD), ... therapeutic products for the prevention and treatment of ... notice on July 18, 2014 from the NYSE ... the CorMedix plan to regain compliance with continued ... the NYSE-MKT is continuing the Company,s listing and ...
    (Date:7/24/2014)... 24, 2014  Neogen Corporation (Nasdaq: NEOG ... its potential revenue from new rodenticide research are premature. ... analysts on July 22, 2014, Neogen,s CEO commented about ... research. "It was my intent Tuesday at ... of a new type of rodenticide, but certainly not ...
    (Date:7/24/2014)... Toronto, Canada (PRWEB) July 24, 2014 ... for Optimizing Dose Escalation in First in Human Studies” ... to make better go/no-go decisions. , With increasing R&D ... market, pharmaceutical companies need to maximize the knowledge collected ... go/no-go decisions and improve success in late stage development. ...
    Breaking Biology Technology:Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3Neogen comments on SenesTech 2Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2
    ... February 2, 2009 Reston, Va. The American ... book, Frontiers of Propulsion Science , that compiles ... novel propulsion concepts as space drives, warp drives, gravity ... and enable human voyages to other star systems. ...
    ... Pharmaceuticals Inc.,(Nasdaq: TRBN ) today announced that executives ... at two upcoming investor conferences in,February and March: , ... Conference at the Waldorf Astoria, 301 Park,Ave., in New York ... to present at 9 a.m. EST. A replay of the ...
    ... CAMBRIDGE, Mass., Feb. 3 Abt Associates announced that ... Associate. After a brief orientation to the firm, ... education work in September 2009. Dr. Takai brings ... and management of federal evaluation studies in the field ...
    Cached Biology Technology:New book from AIAA explores space drives, warp drives 2Trubion Announces Presentations at Upcoming Investor Conferences 2Dr. Ricky Takai, Expert in Designing and Managing Federal Evaluation Studies in Education, Joins Abt Associates 2
    (Date:7/25/2014)... PITTSBURGH -- The routine use of a molecular ... likelihood of performing the correct initial surgery for ... from the University of Pittsburgh Cancer Institute (UPCI), ... the UPMC/UPCI Multidisciplinary Thyroid Center and other diagnostic ... the correct initial surgery by 30 percent, according ...
    (Date:7/24/2014)... wildlife loss leads to conflict among people around the ... Society (WCS) Health & Ecosystems: Analysis of Linkages (HEAL) ... approach to tackle global biodiversity decline. , The harvest ... world,s people and provides protein for more than a ... no surprise that today,s unprecedented loss of wildlife, is ...
    (Date:7/24/2014)... food or commercial food sale, has been heavily documented ... many species of primates and other mammals. However, ... the species being consumed are birds, particularly large birds ... meat made available for sale but the meat that ... brought to villages for consumption, we noted a significant ...
    Breaking Biology News(10 mins):Test increases odds of correct surgery for thyroid cancer patients 2Test increases odds of correct surgery for thyroid cancer patients 3New study draws links between wildlife loss and social conflicts 2
    ... Cambridge and Boston, MA. Wed. July 4, 2012 One ... after treatment. In the case of many forms of cancer, ... eradicate cancer cells in the lab, but often produce only ... in the field of cancer research has been and remains: ...
    ... new type of scholarly articles, which are rapidly gaining ... publications that describe data sets and provide an opportunity ... citation and re-use of the published data. Data Papers ... among the international organization Global Biodiversity Information Facilities ...
    ... coast of North America is reaching the level of the ... by a researcher at the University of British Columbia. ... Bulletin , examined stomach contents of beached northern fulmars on ... Washington and Oregon, U.S.A. "Like the canary in the ...
    Cached Biology News:Tumor microenvironment helps skin cancer cells resist drug treatment 2Tumor microenvironment helps skin cancer cells resist drug treatment 3Tumor microenvironment helps skin cancer cells resist drug treatment 4A new type of data papers designed to publish online interactive keys identifying biodiversity 2Seabirds study shows plastic pollution reaching surprising levels off coast of Pacific Northwest 2
    ... 1;heading 2;Many mammalian ... experimental situations create ... transfection and other ... ViraPower Lentiviral Expression ...
    ... Rabbit polyclonal to Kv4.2 Immunogen ... corresponding to amino acids 23-43 of Rat ... with Rat.Expected to cross-react with Human (100% ... immunogen), Rabbit (100% identity with immunogen) and ...
    RayBio Human Angiogenesis Antibody Array 2.1 (8 array membranes) with Accessory, detects 23 angiogenic factors (for lysate) Class: Antibody Array Products Product Group: Antibody Array...
    ... Cryo/CryoPlus Inventory Racks for ... available with cardboard or stainless ... or 5ml cryo vials. ... racks available. Platform risers ...
    Biology Products: